NYSE American - Nasdaq Real Time Price USD
Kairos Pharma, Ltd. (KAPA)
0.5206
+0.0706
+(15.69%)
At close: June 4 at 4:00:00 PM EDT
0.4776
-0.03
(-6.08%)
Pre-Market: 4:58:37 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.05 | -0.05 | -0.19 | -0.4 |
| Low Estimate | -0.05 | -0.05 | -0.19 | -0.4 |
| High Estimate | -0.05 | -0.05 | -0.19 | -0.4 |
| Year Ago EPS | -- | -0.1 | -0.18 | -0.19 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|
| EPS Est. | -0.02 | -0.02 | -0.05 |
| EPS Actual | -0.1 | -0.03 | -0.08 |
| Difference | -0.08 | -0.01 | -0.03 |
| Surprise % | -400.00% | -55.50% | -60.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.05 | -0.19 | -0.4 |
| 7 Days Ago | -0.05 | -0.05 | -0.19 | -0.4 |
| 30 Days Ago | -0.05 | -0.05 | -0.19 | -0.4 |
| 60 Days Ago | 0 | 0 | -0.23 | -0.45 |
| 90 Days Ago | 0 | 0 | -0.23 | -0.45 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KAPA | -- | 50.00% | -7.65% | -110.53% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 6/4/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/17/2025 |
| Initiated | HC Wainwright & Co.: Buy | 4/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/31/2025 |
| Initiated | Maxim Group: Buy | 3/27/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/20/2025 |
Related Tickers
CDT Conduit Pharmaceuticals Inc.
2.6800
-17.03%
PCSA Processa Pharmaceuticals, Inc.
0.3076
+6.69%
TNFA TNF Pharmaceuticals, Inc.
0.1639
-2.32%
TOVX Theriva Biologics, Inc.
0.4580
-2.55%
ESLA Estrella Immunopharma, Inc.
0.9900
+18.68%
REVB Revelation Biosciences, Inc.
0.8844
-1.81%
SILO Silo Pharma, Inc.
0.5710
+15.17%
ENTO Entero Therapeutics, Inc.
0.4477
-0.73%
ATHA Athira Pharma, Inc.
0.3300
+9.16%
CERO CERo Therapeutics Holdings, Inc.
0.4500
-4.05%